title: CDX-2 should be included in the work-up of patients with lung metastases from unknown primary.
authors.forename: N
authors.initials: N
authors.lastname: Fazio
authors.forename: T
authors.initials: T
authors.lastname: De Pas
authors.forename: F
authors.initials: F
authors.lastname: de Braud
authors.forename: L
authors.initials: L
authors.lastname: Spaggiari
authors.forename: G
authors.initials: G
authors.lastname: Mazzarol
authors.forename: R
authors.initials: R
authors.lastname: Biffi
authors.forename: B
authors.initials: B
authors.lastname: Andreoni
authors.forename: M
authors.initials: M
authors.lastname: Zampino
authors.forename: G
authors.initials: G
authors.lastname: Curigliano
authors.forename: K
authors.initials: K
authors.lastname: Lorizzo
authors.forename: G
authors.initials: G
authors.lastname: Di Meglio
authors.forename: A
authors.initials: A
authors.lastname: Goldhirsch
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis / Q000556:secondary*; D014408:Biomarkers, Tumor / Q000032:analysis*; D000071616:CDX2 Transcription Factor; D003110:Colonic Neoplasms / Q000175:diagnosis / Q000473:pathology*; D003937:Diagnosis, Differential; D018398:Homeodomain Proteins / Q000032:analysis* / Q000096:biosynthesis; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology / Q000556:secondary*; D008297:Male; D008875:Middle Aged; D009382:Neoplasms, Unknown Primary / Q000175:diagnosis*; D015534:Trans-Activators / Q000032:analysis* / Q000096:biosynthesis
chemical_list: D014408:Biomarkers, Tumor; D000071616:CDX2 Transcription Factor; D018398:Homeodomain Proteins; D015534:Trans-Activators